Novo Nordisk A/S (NVO)
Market Closed
15 Oct, 08:00 PM
BCBA BCBA Primary AR$
9,055. 00
+285
+3.2497%
AR$
- Market Cap
48.26 P/E Ratio
0.32% Div Yield
36,032 Volume
0 Eps
AR$ 8,770
Previous Close Want to track NVO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Novo Nordisk A/S (NVO) Statistics
Valuation metrics
Market Cap -
Enterprise value 8.81P
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) 0.74
Enterprise Value/Revenue 116.89
Enterprise Value/EBITDA 221.72
Overview
Shares outstanding -
Float 3.17B
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 16.38K
Average volume (90 days) 14.28K
Price summary
52-Week low 8,480
52-Week high 11,920
Beta 0.34
50-Day moving average 10,178.7
200-Day moving average 10,194.84
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 11.7
Trailing annual dividend yield 0.0013%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 21 Aug 2026
Ex-Dividend Date 14 Aug 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.35%
Operating margin 0.43%
Operational effectiveness
Return on assets 0.19%
Return on equity 0.6%
Income Statement
Revenue (ttm) 75.32T
Revenue per share (ttm) 74.19
Quarterly revenue growth (yoy) 0.02%
Gross profit (ttm) 61.76T
EBITDA 39.71T
Net income to common (ttm) 26.62T
Diluted EPS (ttm) -
Quarterly earnings growth (yoy) -0.21%
Balance Sheet
Total cash (mrq) 10.29T
Total cash per share (mrq) 10.16
Total debt (mrq) 32.04T
Total Debt/Equity (mrq) 63.33
Current ratio (mrq) 0.87%
Book value per share (mrq) 11,642.57
Cash Flow
Cash flow statement 30.15T
Levered free cash flow (LFCF) 8.61T
2026 © Marketlog. All Rights Reserved.
